Neurontin (Gabapentin)

Gabapentin, the active ingredient in Neurontin, is an anticonvulsant (gabapentinoid) presented as an oral tablet for systemic use. It is indicated for the management of partial seizures, postherpetic neuralgia, diabetic peripheral neuropathy and restless‑legs syndrome in adult patients.

GNH USA supplies Neurontin as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics across global markets, with a focus on European Union regulatory standards. The company ensures consistent quality and reliable delivery for both short‑term and long‑term procurement needs.

Neurontin (gabapentin) is used to treat disorders involving abnormal neuronal excitability and neuropathic pain.

Partial seizures: reduces seizure frequency in epilepsy patients. Postherpetic neuralgia: alleviates chronic pain following shingles. Diabetic peripheral neuropathy: improves pain and sensory symptoms in diabetes‑related nerve damage. Restless legs syndrome: decreases the urge to move the legs and improves sleep quality.

Gabapentin may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness - Somnolence - Peripheral edema - Nausea

Serious or Rare Side Effects: - Severe allergic reactions (e.g., Stevens‑Johnson syndrome) - Suicidal thoughts or behavior - Respiratory depression

When prescribing gabapentin, several safety considerations should be observed.

Renal function: dose may need adjustment in patients with impaired renal clearance. Pregnancy: safety not established; use only if potential benefit justifies risk. Elderly: increased sensitivity to CNS effects; monitor for dizziness and falls. Concomitant CNS depressants: may enhance sedation and respiratory depression. Suicidality: monitor for mood changes and suicidal ideation. Store at ambient temperature: keep tablets in original container, protect from moisture and heat.

Gabapentin can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce gabapentin absorption; separate dosing by at least 2 hours. - Opioids: combined use may increase risk of respiratory depression and sedation. - CNS depressants (e.g., benzodiazepines): may potentiate sedation and dizziness.

Moderate Interactions (Monitor Closely): - Anticonvulsants (e.g., carbamazepine): may lower gabapentin levels. - Diuretics: may affect renal clearance of gabapentin. - Alcohol: additive CNS depression.